Veracyte (VCYT) Equity Ratio (2012 - 2026)

Veracyte (VCYT) has 15 years of Equity Ratio data on file, last reported at 0.94 in Q1 2026.

• Quarterly Equity Ratio rose 3.03% year-over-year to 0.94 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.94 (up 3.03% YoY) and the FY2025 annual result came in at 0.93, up 2.97% from the prior year.
• Equity Ratio was little changed at 0.94 in Q1 2026 per VCYT's latest filing, from 0.93 in the prior quarter.
• The five-year high for Equity Ratio was 0.94 in Q3 2023, with the low at 0.9 in Q4 2024.
• Average Equity Ratio over 5 years is 0.93, with a median of 0.93 recorded in 2022.
• Year-over-year, Equity Ratio decreased 3.41% in 2024 and climbed 3.03% in 2026.
• Veracyte's Equity Ratio stood at 0.93 in 2022, then increased by 0.72% to 0.94 in 2023, then slipped by 3.41% to 0.9 in 2024, then advanced by 2.97% to 0.93 in 2025, then advanced by 0.49% to 0.94 in 2026.
• Business Quant data shows VCYT's Equity Ratio at 0.94 in Q1 2026, 0.93 in Q4 2025, and 0.92 in Q3 2025.